Cancer screening does not prevent cancer by finding it — it prevents cancer by finding what comes before it. Cervical cancer screening detects HPV infection and precancerous cervical dysplasia years before invasive cancer develops. Endometrial cancer is identified early when women report postmenopausal bleeding rather than dismissing it. Ovarian cancer — the most difficult to detect — is caught at a more treatable stage when its warning signs are recognized and acted on rather than attributed to other causes. And women with hereditary risk factors identified through family history and genetic testing receive targeted surveillance that dramatically improves their outcomes compared with women whose elevated risk was never recognized.
The gynecologist is the primary point of contact for most women’s cancer screening needs. The well-woman visit is not simply an annual formality — it is the clinical encounter where screening status is reviewed, family history is updated, new symptoms are evaluated, and screening recommendations are tailored to each woman’s individual risk profile. At Lapeer Women’s Health, cancer prevention is embedded in every well-woman visit and addressed specifically as a clinical priority at every age.
Each page in this cluster addresses a specific domain of gynecologic cancer screening and prevention in depth. Together they cover the full scope of cancer risk that a gynecologic practice is positioned to identify, screen for, and act on.
Cervical Cancer Screening
Cervical cancer is among the most preventable cancers in medicine — because its causative agent (HPV) is known, its precancerous phase is long and detectable, and the screening system that identifies and treats precancerous changes before invasion occurs is highly effective when used consistently. Current Pap and HPV co-testing guidelines, vaccination recommendations, and the complete cervical cancer prevention pathway are covered in depth. Learn more →
Postmenopausal Bleeding & Cancer Risk
Postmenopausal bleeding — any vaginal bleeding that occurs after 12 consecutive months without a period — is never normal and always requires evaluation. Endometrial cancer presents as postmenopausal bleeding in the majority of cases, and when identified at this stage, before symptoms are dismissed or attributed to other causes, it is highly curable. The evaluation that begins with postmenopausal bleeding and ends with a definitive diagnosis is straightforward — and the cost of delaying it is not. Learn more →
Breast Cancer Screening Referrals
The gynecologist performs clinical breast examination and coordinates referrals for mammography and supplemental breast imaging — often serving as the provider who ensures breast cancer screening is current, who identifies women who may benefit from supplemental MRI screening based on density or risk, and who acts on breast examination findings that warrant further evaluation. Breast cancer screening recommendations by age and risk category are reviewed at the well-woman visit at Lapeer Women’s Health. Learn more →
Family History & Gynecologic Cancer Risk
Family history of breast, ovarian, endometrial, or colorectal cancer is one of the most powerful predictors of individual cancer risk — and one of the most underutilized pieces of clinical information in gynecologic care. A detailed, three-generation family history reviewed at the well-woman visit identifies women who may benefit from genetic counseling, enhanced screening, or prophylactic interventions that dramatically reduce cancer risk. Many women with significant hereditary cancer risk have never had it recognized because no one took a thorough family history. Learn more →
Genetic Testing for Cancer Risk
BRCA1 and BRCA2 mutations, Lynch syndrome, and other hereditary cancer syndromes confer dramatically elevated lifetime risks of gynecologic and other cancers that standard population-based screening does not adequately address. Genetic testing — when appropriately indicated by personal or family history — identifies women who need individualized high-risk management including enhanced surveillance, chemoprevention, and potentially risk-reducing surgery. The clinical pathway from family history concern to genetic counseling referral to result-based management is coordinated at Lapeer Women’s Health. Learn more →
Ovarian Cancer Warning Signs
Ovarian cancer is the most lethal gynecologic cancer because it is diagnosed at an advanced stage in the majority of cases — not because it is inherently untreatable when found early. The warning signs of ovarian cancer are real, recognizable, and frequently attributed to more common benign conditions for months before the diagnosis is made. Understanding which symptoms warrant prompt gynecologic evaluation — and advocating for that evaluation — is one of the most important things a woman can do for her own cancer outcomes. Learn more →
The following symptoms should not be dismissed or watched for more than a few weeks before seeking evaluation:
- Any vaginal bleeding after menopause — even a small amount, even once — requires evaluation
- New, persistent pelvic or abdominal bloating, pressure, or fullness that is different from your normal pattern
- New difficulty eating or feeling full quickly that has persisted for more than a few weeks
- New urinary urgency or frequency without an identified infection in a postmenopausal woman
- Unexplained pelvic or abdominal pain that is new, persistent, or worsening
Understanding cancer risk is not about predicting inevitability — it is about identifying which women need closer surveillance, which need genetic evaluation, and which modifiable factors can meaningfully reduce risk.
Cervical Cancer Risk
Virtually all cervical cancer is caused by persistent infection with high-risk HPV strains. Risk factors that increase the probability of HPV persistence and dysplasia progression include: smoking (which significantly impairs local cervical immune defense), immunosuppression from any cause, early sexual debut, multiple sexual partners, and failure to maintain current Pap and HPV screening. HPV vaccination dramatically reduces risk for the strains covered by the vaccine. Consistent cervical cancer screening is the most powerful preventive intervention available for women who are sexually active regardless of vaccination status.
Endometrial Cancer Risk
Endometrial cancer is the most common gynecologic malignancy in the United States. The primary driver is sustained exposure of the uterine lining to estrogen without adequate progesterone opposition. Risk factors include obesity (adipose tissue produces estrogen independently of the ovaries), diabetes, unopposed estrogen therapy, late menopause, nulliparity, and Lynch syndrome. Combined oral contraceptives and progestin-containing IUDs significantly reduce endometrial cancer risk by providing progestin exposure to the uterine lining — a non-contraceptive benefit that is relevant to the contraceptive counseling conversation at Lapeer Women’s Health. PCOS is an independent risk factor through the mechanism of chronic anovulation and unopposed estrogen.
Ovarian Cancer Risk
Ovarian cancer risk is influenced primarily by genetics and ovulatory history. BRCA1 and BRCA2 mutations confer lifetime ovarian cancer risks of 40 to 46 percent and 11 to 27 percent respectively — compared to a 1.4 percent lifetime risk in the general population. Each ovulatory cycle produces minor trauma to the ovarian surface; factors that reduce lifetime ovulatory cycles (oral contraceptive use, pregnancy, breastfeeding) reduce ovarian cancer risk. Women with a significant family history of ovarian, breast, or colorectal cancer require specific risk assessment and potentially genetic counseling to determine whether their risk warrants enhanced surveillance or prophylactic intervention.
Hereditary Cancer Syndromes
A minority of gynecologic cancers occur in the context of hereditary cancer syndromes where the risk is dramatically elevated above the population baseline. BRCA1/2 mutations are associated with significantly elevated breast and ovarian cancer risk. Lynch syndrome (hereditary nonpolyposis colorectal cancer) is associated with elevated endometrial and ovarian cancer risk alongside colorectal cancer risk. Identifying these syndromes requires taking a detailed three-generation family history, recognizing the patterns that suggest hereditary risk, and referring for genetic counseling when indicated. Women whose hereditary risk is identified can access interventions — enhanced surveillance, chemoprevention, prophylactic surgery — that reduce their cancer risk substantially.
Cancer screening and prevention at Lapeer Women’s Health is integrated into every well-woman visit and addressed with specific clinical attention by Dr. Ramona D. Andrei, MD, PhD, FACOG.
Screening Status Review at Every Well-Woman Visit
Every well-woman visit at Lapeer Women’s Health includes a systematic review of current screening status: cervical cancer screening interval and last result, breast cancer screening status and last mammogram, colorectal cancer screening status, and any new symptoms that have developed since the last visit. Overdue screening is identified and addressed proactively rather than waiting for the patient to raise it.
Family History Assessment and Risk Stratification
A detailed family history of cancer — type, age at diagnosis, maternal and paternal lineage — is reviewed and updated at the annual well-woman visit. Women whose family history suggests hereditary cancer risk receive specific discussion of what that risk means, what enhanced screening or genetic evaluation is recommended, and how to access genetic counseling through our affiliated network.
Symptom Evaluation Without Delay
New symptoms that may reflect gynecologic cancer — postmenopausal bleeding, persistent pelvic bloating, pressure or pain, new urinary or bowel changes — are evaluated promptly at Lapeer Women’s Health rather than observed and reassured. The evaluation that identifies early cancer is the same evaluation that rules it out — and its value is the same in either case.
The cancers with the best outcomes are the ones found before they produce symptoms — because symptoms often mean the cancer has advanced beyond the stage where treatment is simplest and most effective. Cervical cancer found at Stage I has a five-year survival rate above 90 percent. Endometrial cancer found at Stage I has a five-year survival rate above 95 percent. Ovarian cancer found at Stage I has a five-year survival rate above 90 percent. The same cancers found at Stage III or IV have survival rates that are a fraction of these numbers.
The annual well-woman visit at Lapeer Women’s Health — at either our Lapeer or Rochester Hills offices — is the mechanism by which screening is kept current, risk is assessed, and early symptoms are evaluated before they become late findings. No referral required.
Gynecologic Cancer Screening
Our team at Lapeer Women’s Health provides comprehensive gynecologic cancer screening and risk assessment at both our Lapeer and Rochester Hills offices. No referral required.
Schedule a Gynecologic VisitThe information on this page is intended for educational purposes only and does not constitute medical advice. Individual risk factors, screening intervals, and management plans vary significantly based on personal and family history. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.